A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects

Alexandru D.P. Papoiu, Hui Wang, Leigh Nattkemper, Hong Liang Tey, Yozo Ishiuji, Yiong Huak Chan, Martin Schmelz, Gil Yosipovitch

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Nerve growth factor (NGF) was reported to be increased in the serum and skin of atopic dermatitis (AD) patients, to the extent that serum nerve growth factor levels were proposed to serve as a marker of disease severity. We studied NGF levels in the serum and dermis using skin microdialysis and attempted to correlate them with disease severity. We also examined if potential differences between morning and evening levels of NGF can explain the phenomenon of nocturnal itch. In addition, neurogenic inflammation and itch were induced using histamine iontophoresis in lesional and non-lesional skin and the effect of experimental itch on dermal NGF concentration was examined. We found that systemic (serum) and eczematous skin levels of NGF in AD are significantly lower in comparison to healthy controls. Serum NGF decreases from morning to late afternoon in both groups. Interestingly, serum NGF levels were correlated to disease severity in the morning in AD, although the NGF concentration in AD were significantly lower than in the healthy group. The local itch and neurogenic inflammation induction via experimental histamine reduced local NGF levels in the eczema and non-lesional skin in atopics, but not in the healthy controls, where it was slightly increased. The higher the clinical severity of the eczema, a significantly less pronounced effect of neurogenic inflammation on the local levels of NGF was found. The availability of measurable NGF might be reduced by a higher expression of NGF receptors. The fluctuations of NGF levels during the day suggest a complex modulation of this neurotrophin, potentially linked to stress or to an altered neurophysiological mechanism.

Original languageEnglish (US)
Pages (from-to)417-422
Number of pages6
JournalNeuropeptides
Volume45
Issue number6
DOIs
StatePublished - Dec 1 2011
Externally publishedYes

Fingerprint

Nerve Growth Factor
Atopic Dermatitis
Healthy Volunteers
Skin
Serum
Neurogenic Inflammation
Eczema
Histamine
Nerve Growth Factor Receptors
Iontophoresis
Microdialysis
Nerve Growth Factors
Dermis

Keywords

  • Atopic dermatitis
  • Daily fluctuation
  • Histamine
  • Itch
  • Nerve growth factor (NGF) levels

ASJC Scopus subject areas

  • Endocrinology
  • Neurology
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience

Cite this

A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects. / Papoiu, Alexandru D.P.; Wang, Hui; Nattkemper, Leigh; Tey, Hong Liang; Ishiuji, Yozo; Chan, Yiong Huak; Schmelz, Martin; Yosipovitch, Gil.

In: Neuropeptides, Vol. 45, No. 6, 01.12.2011, p. 417-422.

Research output: Contribution to journalArticle

Papoiu, ADP, Wang, H, Nattkemper, L, Tey, HL, Ishiuji, Y, Chan, YH, Schmelz, M & Yosipovitch, G 2011, 'A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects', Neuropeptides, vol. 45, no. 6, pp. 417-422. https://doi.org/10.1016/j.npep.2011.07.008
Papoiu, Alexandru D.P. ; Wang, Hui ; Nattkemper, Leigh ; Tey, Hong Liang ; Ishiuji, Yozo ; Chan, Yiong Huak ; Schmelz, Martin ; Yosipovitch, Gil. / A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects. In: Neuropeptides. 2011 ; Vol. 45, No. 6. pp. 417-422.
@article{082614096984494f930fc13d34020ad7,
title = "A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects",
abstract = "Nerve growth factor (NGF) was reported to be increased in the serum and skin of atopic dermatitis (AD) patients, to the extent that serum nerve growth factor levels were proposed to serve as a marker of disease severity. We studied NGF levels in the serum and dermis using skin microdialysis and attempted to correlate them with disease severity. We also examined if potential differences between morning and evening levels of NGF can explain the phenomenon of nocturnal itch. In addition, neurogenic inflammation and itch were induced using histamine iontophoresis in lesional and non-lesional skin and the effect of experimental itch on dermal NGF concentration was examined. We found that systemic (serum) and eczematous skin levels of NGF in AD are significantly lower in comparison to healthy controls. Serum NGF decreases from morning to late afternoon in both groups. Interestingly, serum NGF levels were correlated to disease severity in the morning in AD, although the NGF concentration in AD were significantly lower than in the healthy group. The local itch and neurogenic inflammation induction via experimental histamine reduced local NGF levels in the eczema and non-lesional skin in atopics, but not in the healthy controls, where it was slightly increased. The higher the clinical severity of the eczema, a significantly less pronounced effect of neurogenic inflammation on the local levels of NGF was found. The availability of measurable NGF might be reduced by a higher expression of NGF receptors. The fluctuations of NGF levels during the day suggest a complex modulation of this neurotrophin, potentially linked to stress or to an altered neurophysiological mechanism.",
keywords = "Atopic dermatitis, Daily fluctuation, Histamine, Itch, Nerve growth factor (NGF) levels",
author = "Papoiu, {Alexandru D.P.} and Hui Wang and Leigh Nattkemper and Tey, {Hong Liang} and Yozo Ishiuji and Chan, {Yiong Huak} and Martin Schmelz and Gil Yosipovitch",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/j.npep.2011.07.008",
language = "English (US)",
volume = "45",
pages = "417--422",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "6",

}

TY - JOUR

T1 - A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects

AU - Papoiu, Alexandru D.P.

AU - Wang, Hui

AU - Nattkemper, Leigh

AU - Tey, Hong Liang

AU - Ishiuji, Yozo

AU - Chan, Yiong Huak

AU - Schmelz, Martin

AU - Yosipovitch, Gil

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Nerve growth factor (NGF) was reported to be increased in the serum and skin of atopic dermatitis (AD) patients, to the extent that serum nerve growth factor levels were proposed to serve as a marker of disease severity. We studied NGF levels in the serum and dermis using skin microdialysis and attempted to correlate them with disease severity. We also examined if potential differences between morning and evening levels of NGF can explain the phenomenon of nocturnal itch. In addition, neurogenic inflammation and itch were induced using histamine iontophoresis in lesional and non-lesional skin and the effect of experimental itch on dermal NGF concentration was examined. We found that systemic (serum) and eczematous skin levels of NGF in AD are significantly lower in comparison to healthy controls. Serum NGF decreases from morning to late afternoon in both groups. Interestingly, serum NGF levels were correlated to disease severity in the morning in AD, although the NGF concentration in AD were significantly lower than in the healthy group. The local itch and neurogenic inflammation induction via experimental histamine reduced local NGF levels in the eczema and non-lesional skin in atopics, but not in the healthy controls, where it was slightly increased. The higher the clinical severity of the eczema, a significantly less pronounced effect of neurogenic inflammation on the local levels of NGF was found. The availability of measurable NGF might be reduced by a higher expression of NGF receptors. The fluctuations of NGF levels during the day suggest a complex modulation of this neurotrophin, potentially linked to stress or to an altered neurophysiological mechanism.

AB - Nerve growth factor (NGF) was reported to be increased in the serum and skin of atopic dermatitis (AD) patients, to the extent that serum nerve growth factor levels were proposed to serve as a marker of disease severity. We studied NGF levels in the serum and dermis using skin microdialysis and attempted to correlate them with disease severity. We also examined if potential differences between morning and evening levels of NGF can explain the phenomenon of nocturnal itch. In addition, neurogenic inflammation and itch were induced using histamine iontophoresis in lesional and non-lesional skin and the effect of experimental itch on dermal NGF concentration was examined. We found that systemic (serum) and eczematous skin levels of NGF in AD are significantly lower in comparison to healthy controls. Serum NGF decreases from morning to late afternoon in both groups. Interestingly, serum NGF levels were correlated to disease severity in the morning in AD, although the NGF concentration in AD were significantly lower than in the healthy group. The local itch and neurogenic inflammation induction via experimental histamine reduced local NGF levels in the eczema and non-lesional skin in atopics, but not in the healthy controls, where it was slightly increased. The higher the clinical severity of the eczema, a significantly less pronounced effect of neurogenic inflammation on the local levels of NGF was found. The availability of measurable NGF might be reduced by a higher expression of NGF receptors. The fluctuations of NGF levels during the day suggest a complex modulation of this neurotrophin, potentially linked to stress or to an altered neurophysiological mechanism.

KW - Atopic dermatitis

KW - Daily fluctuation

KW - Histamine

KW - Itch

KW - Nerve growth factor (NGF) levels

UR - http://www.scopus.com/inward/record.url?scp=83355169615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83355169615&partnerID=8YFLogxK

U2 - 10.1016/j.npep.2011.07.008

DO - 10.1016/j.npep.2011.07.008

M3 - Article

C2 - 21893340

AN - SCOPUS:83355169615

VL - 45

SP - 417

EP - 422

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 6

ER -